10 days after Michelle Taylor was diagnosed with ocular melanoma, her affected eye was removed. New ocular melanoma therapies are urgently needed so that patients like Michelle don’t have to go through life altering surgery. Donate to OM research: masc.org.au/donate-to-ocul…

A great start to the 2024 AOMA Virtual Summit, with US speakers Dr Richard Carvajal covering international clinical trials and Melody Burchett from A Cure In Sight on advocacy and mental health for patients. Joined by meeting convenor, Dr Tim Isaacs.

ONCODOC Australasian Ocular Melanoma Alliance (AOMA) Melanoma and Skin Cancer Trials (MASC Trials) Shackleton Laboratory Matteo Carlino CURE Ocular Melanoma Melanoma Institute Australia Great to hear from patient advocates like Melody Burchett A Cure In Sight highlighting importance of patient advocacy, clinical trials and unmet emotional needs of UM pts. Will be sharing learnings on #fearofrecurrence and how pts/drs can better support this unmet need. POCOG

Interesting activity and tolerability of antibody drug conjugates targeting GNAQ/11 with non-cytotoxic payload in uveal melanoma presented by Matteo Carlino at #AOMA24 Summit Australasian Ocular Melanoma Alliance (AOMA) Melanoma and Skin Cancer Trials (MASC Trials)

2024 AOMA Summit continues with A/Prof Matt Carlino from Melanoma Institute Australia talking about targeting GNAQ and GNA11 in uveal melanoma, and Anne Goulter from NZ who travels to Australia each week for a Tebentafusp infusion. ONCODOC Melanoma and Skin Cancer Trials (MASC Trials)

If you missed Illana Klevansky's talk about her ocular melanoma journey at today's AOMA Summit, you can read it here: masc.org.au/illana/ Melanoma and Skin Cancer Trials (MASC Trials)

👁️ Videos of the 2024 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit held on Sat 15 June are now available online. Watch all the sessions or only the videos you are interested in. masc.org.au/aoma-summit/ ONCODOC Jonas Nilsson Susan Vine Shell Taylor

High-quality clinical trials require continuous funding to deliver real-world results. Help us to conquer melanoma and skin cancer through clinical trials by making a tax-deductible donation before 30 June 2024. Learn more and donate: masc.org.au/donate/

🚨 Time is running out to make a difference for ocular melanoma patients. Thanks to advocates like Susan Vine, support and awareness of this rare cancer is growing. But funding is urgently needed to improve outcomes for ocular melanoma patients. Donate: masc.org.au/donate-to-ocul…

We are pleased that Melanoma and Skin Cancer Trials (MASC Trials) continue to collaborate with COSA as an Affiliated organisation member. A reminder that MASC Trials members can join COSA at discounted rates! Join or renew here: bit.ly/3s5mOC6

🚨 EOFY is tomorrow! Don’t miss your opportunity to contribute to cutting-edge melanoma and skin cancer clinical trials. By donating, you're supporting innovative research that can help melanoma patients like Ana Ratapu. Please donate: masc.org.au/donate/

Congratulations to Shirley Potter, 🇮🇪 CI and PI at Mater Hospital Advanced Cancer Care and Marlese Dempsey, PI at Trinity St James's Cancer Institute on recruiting the first six patients to the Melanoma and Skin Cancer Trials (MASC Trials) MelMarT-II study 👏 St James's Hospital Melanoma Support Ireland 🖤 MaterSurgery

Prof Pascale Guitera, faculty member Melanoma Institute Australia & Professor University of Sydney is presenting ‘Alternative treatment for lentigo maligna: review of evidence & the RADICAL trial’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/

Prof Michael Henderson is Professor of Surgery University of Melbourne and surgeon Peter Mac Cancer Centre. Hear Prof Henderson’s talk ‘Melanoma Margins Trial: MelMarT-II’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/

Our Consumer Advisory Panel has welcomed a new member to represent Merkel cell carcinoma (MCC) patients. Trevor Day was diagnosed with MCC – a rare form of skin cancer – in 2020. Trevor hopes to help people understand the physical and mental aspects of dealing with MCC.

Anne Gately is a stage IV melanoma survivor, author of Sunburnt & wants to change the ‘bronzed Aussie’ culture. Hear her talk on ‘How Australia’s culture primed us for skin cancer’ at the 2024 MASC Trials ASM, 24 Oct 2024, Sydney. Register: masc.org.au/asm-2024/ Melanoma Institute Australia

🌟Young auctioneers raise nearly $30,000 for Melanoma and Skin Cancer Trials at Brisbane event🌟 Melanoma & Skin Cancer Trials was chosen as ALPA's 2024 charity. So far, ALPA has raised $91,075 to support our efforts to conquer melanoma and skin cancer through clinical trials.👏

📢 ASM Program available! ✅2 keynote speakers ✅17 melanoma and skin cancer clinical trial experts ✅6 consumers with unique perspectives on clinical trials. Visit the MASC Trials ASM website for program & speaker info. Register ASAP - seats are limited! masc.org.au/asm-2024/

BETTER trial is investigating new treatment combo using immunotherapy drugs & targeted radiotherapy for patients with melanoma brain metastases. Thanks to a generous donation from AustralianSkinCancerFoundation Foundation, this trial is in start-up phase. masc.org.au/better/ Malaka Ameratunga

Dr Wen Xu, senior lecturer at University of Queensland is presenting ‘Immunotherapy Merkel Adjuvant Trial (I-MAT) and Australasian Merkel Cell Carcinoma Interest Group (AMIGOs)’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/